🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
213.10
+0.40 (0.19%)
Nov 20, 2026, 11:17 AM CET

Zealand Pharma Cash Flow Statement

Millions DKK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,0906,455-1,079-703.74-1,202-1,018
Depreciation & Amortization
35.0124.0123.1220.12101.5727.82
Other Amortization
23.3820.3816.491.21.34-
Asset Writedown & Restructuring Costs
---4.71-0.76.52
Stock-Based Compensation
145.89115.8987.0361.4352.2953.5
Other Operating Activities
-857.08-171.08-96.39138.5181.67-130.47
Change in Accounts Receivable
-3,530-88.26-48.96-6.7626.64-64.49
Change in Inventory
-0.310.7-2.769.3418.22-52.77
Change in Accounts Payable
-15.34-178.3489.9239.8421.55-49.06
Change in Income Taxes
111.06546.06-4.62---
Change in Other Net Operating Assets
-484.43-202.4384.199.68-56.25-
Operating Cash Flow
-1,4826,532-930.82-425.67-942.31-1,212
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-51.37-33.37-10.05-11.24-11.71-22.13
Sale (Purchase) of Intangibles
-34.71-35.71-3.1-12.51--
Investment in Securities
-6.43-2,179-7,293-1,070186.58-
Other Investing Activities
----106.394.01
Investing Cash Flow
-92.51-2,249-7,307-1,094281.26-18.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--369.87--647.91
Long-Term Debt Repaid
--20.16-16.44-543.43-449.81-14.72
Lease Payments
-31.16-20.16-16.44-17.66-13.72-14.72
Net Debt Issued (Repaid)
-31.16-20.16353.43-543.43-449.81633.19
Issuance of Common Stock
33.1549.158,5231,5641,085775.05
Repurchase of Common Stock
-1,195-407.17-351.83-41.6--28.59
Other Financing Activities
---236.58-71.91-47.35-46.9
Financing Cash Flow
-1,193-378.188,288907.01587.51,333

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
87.26-54.746.23-7.2413.6866.22
Net Cash Flow
-2,6803,85157.39-619.92-59.87168.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,5336,499-940.87-436.91-954.02-1,234
Free Cash Flow Growth
------
Free Cash Flow Margin
-33.35%70.52%-1500.80%-127.46%-917.45%-1136.94%
Free Cash Flow Per Share
-21.7290.83-14.16-7.72-20.65-28.79
Levered Free Cash Flow
-1,6904,392-736.41-228.98-384.08-589.73
Unlevered Free Cash Flow
-1,6894,393-728.89-213.78-349.29-587.18
Free Cash Flow After Leases
-1,5656,478-957.31-454.57-967.74-1,249

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
28.3322.3324.0325.2534.123.3
Cash Income Tax Paid
567.37567.37-11.16-11.3-9.2841.63
Change in Working Capital
-3,91987.73117.7652.110.16-166.33